Nickel Complexes of C-Substituted Cyclams and Their Activity for CO(2) and H(+) Reduction

por Cook, Timothy D., Tyler, Sarah F., McGuire, Caitlyn M., Zeller, Matthias, Fanwick, Phillip E., Evans, Dennis H., Peters, Dennis G., Ren, Tong
Publicado 2017

mTOR pathway activation is a favorable prognostic factor in human prostate adenocarcinoma

por Stelloo, Suzan, Sanders, Joyce, Nevedomskaya, Ekaterina, de Jong, Jeroen, Peters, Dennis, van Leenders, Geert J.L.H., Jenster, Guido, Bergman, Andries M., Zwart, Wilbert
Publicado 2016

Patient-Derived Organoid Models of Human Neuroendocrine Carcinoma

por Dijkstra, Krijn K., van den Berg, José G., Weeber, Fleur, van de Haar, Joris, Velds, Arno, Kaing, Sovann, Peters, Dennis D. G. C., Eskens, Ferry A. L. M., de Groot, Derk-Jan A., Tesselaar, Margot E. T., Voest, Emile E.
Publicado 2021

FGFR1, 2 and 3 protein overexpression and molecular aberrations of FGFR3 in early stage non‐small cell lung cancer

por Theelen, Willemijn SME, Mittempergher, Lorenza, Willems, Stefan M, Bosma, Astrid J, Peters, Dennis DGC, van der Noort, Vincent, Japenga, Eva J, Peeters, Ton, Koole, Koos, Šuštić, Tonći, Blaauwgeers, JL, van Noesel, Carel J, Bernards, René, van den Heuvel, Michel M
Publicado 2016

Absence of PD-L1 expression on tumor cells in the context of an activated immune infiltrate may indicate impaired IFNγ signaling in non-small cell lung cancer

por Theelen, Willemijn S. M. E., Kuilman, Thomas, Schulze, Katja, Zou, Wei, Krijgsman, Oscar, Peters, Dennis D. G. C., Cornelissen, Sten, Monkhorst, Kim, Sarma, Pranamee, Sumiyoshi, Teiko, Amler, Lukas C., Willems, Stefan M., Blaauwgeers, Johannes L. G., van Noesel, Carel J. M., Peeper, Daniel S., van den Heuvel, Michel M., Kowanetz, Marcin
Publicado 2019

The Tumor Immune Landscape and Architecture of Tertiary Lymphoid Structures in Urothelial Cancer

por van Dijk, Nick, Gil-Jimenez, Alberto, Silina, Karina, van Montfoort, Maurits L., Einerhand, Sarah, Jonkman, Lars, Voskuilen, Charlotte S., Peters, Dennis, Sanders, Joyce, Lubeck, Yoni, Broeks, Annegien, Hooijberg, Erik, Vis, Daniel J., van den Broek, Maries, Wessels, Lodewyk F. A., van Rhijn, Bas W. G., van der Heijden, Michiel S.
Publicado 2021

Transcription Factor NFIB Is a Driver of Small Cell Lung Cancer Progression in Mice and Marks Metastatic Disease in Patients

por Semenova, Ekaterina A., Kwon, Min-chul, Monkhorst, Kim, Song, Ji-Ying, Bhaskaran, Rajith, Krijgsman, Oscar, Kuilman, Thomas, Peters, Dennis, Buikhuisen, Wieneke A., Smit, Egbert F., Pritchard, Colin, Cozijnsen, Miranda, van der Vliet, Jan, Zevenhoven, John, Lambooij, Jan-Paul, Proost, Natalie, van Montfort, Erwin, Velds, Arno, Huijbers, Ivo J., Berns, Anton
Publicado 2016

Androgen receptor signalling in macrophages promotes TREM-1-mediated prostate cancer cell line migration and invasion

por Cioni, Bianca, Zaalberg, Anniek, van Beijnum, Judy R., Melis, Monique H. M., van Burgsteden, Johan, Muraro, Mauro J., Hooijberg, Erik, Peters, Dennis, Hofland, Ingrid, Lubeck, Yoni, de Jong, Jeroen, Sanders, Joyce, Vivié, Judith, van der Poel, Henk G., de Boer, Jan Paul, Griffioen, Arjan W., Zwart, Wilbert, Bergman, Andries M.
Publicado 2020

Poor Outcome in Postpartum Breast Cancer Patients Is Associated with Distinct Molecular and Immunologic Features

por Lefrère, Hanne, Moore, Kat, Floris, Giuseppe, Sanders, Joyce, Seignette, Iris M., Bismeijer, Tycho, Peters, Dennis, Broeks, Annegien, Hooijberg, Erik, Van Calsteren, Kristel, Neven, Patrick, Warner, Ellen, Peccatori, Fedro Alessandro, Loibl, Sibylle, Maggen, Charlotte, Han, Sileny N., Jerzak, Katarzyna J., Annibali, Daniela, Lambrechts, Diether, de Visser, Karin E., Wessels, Lodewyk, Lenaerts, Liesbeth, Amant, Frédéric
Publicado 2023

PD-1(T) TILs as a Predictive Biomarker for Clinical Benefit to PD-1 Blockade in Patients with Advanced NSCLC

por Hummelink, Karlijn, van der Noort, Vincent, Muller, Mirte, Schouten, Robert D., Lalezari, Ferry, Peters, Dennis, Theelen, Willemijn S.M.E., Koelzer, Viktor H., Mertz, Kirsten D., Zippelius, Alfred, van den Heuvel, Michel M., Broeks, Annegien, Haanen, John B.A.G., Schumacher, Ton N., Meijer, Gerrit A., Smit, Egbert F., Monkhorst, Kim, Thommen, Daniela S.
Publicado 2022

MYC is a clinically significant driver of mTOR inhibitor resistance in breast cancer

por Bhin, Jinhyuk, Yemelyanenko, Julia, Chao, Xue, Klarenbeek, Sjoerd, Opdam, Mark, Malka, Yuval, Hoekman, Liesbeth, Kruger, Dinja, Bleijerveld, Onno, Brambillasca, Chiara S., Sprengers, Justin, Siteur, Bjørn, Annunziato, Stefano, van Haren, Matthijs J., Martin, Nathaniel I., van de Ven, Marieke, Peters, Dennis, Agami, Reuven, Linn, Sabine C., Boven, Epie, Altelaar, Maarten, Jonkers, Jos, Zingg, Daniel, Wessels, Lodewyk F.A.
Publicado 2023